Difference between revisions of "Regimen classes"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
Line 1: Line 1:
 
''The purpose of this page is to define regimen classes that will be used in the HemOnc vocabulary; it is not for other purposes at this time.''
 
''The purpose of this page is to define regimen classes that will be used in the HemOnc vocabulary; it is not for other purposes at this time.''
  
 +
=Alkylator-based regimen=
 
=Anthracycline-based regimen=
 
=Anthracycline-based regimen=
 +
 
=Anti-CD20-based regimen=
 
=Anti-CD20-based regimen=
 
==Rituximab-containing regimen==
 
==Rituximab-containing regimen==

Revision as of 17:48, 3 February 2020

The purpose of this page is to define regimen classes that will be used in the HemOnc vocabulary; it is not for other purposes at this time.

Alkylator-based regimen

Anthracycline-based regimen

Anti-CD20-based regimen

Rituximab-containing regimen

Anti-VEGF biologic therapy

Bevacizumab-containing regimen

Endocrine-based regimen

Antiestrogen therapy

Fluoropyrimidine-based regimen

5-FU-based regimen

Irinotecan-based regimen

Platinum-based regimen

Oxaliplatin-based regimen

Platinum-based chemoradiation

Platinum doublet

Single-agent regimen

Single-agent chemotherapy

Single-agent immunotherapy

Trastuzumab-based regimen

Tyrosine kinase inhibitor therapy

BRAF TKI therapy

EGFR TKI therapy

VEGFR inhibitor therapy